Cell & Gene Therapy Answers: Preclinical Oncology

As the landscape of cell therapy continues to evolve, so are the tools to assess the efficacy of cell therapy in the preclinical space. To better understand Labcorp's Preclinical Oncology role in cell therapy development, we spoke with Sheri Barnes, Associate Director, Scientific Development, Preclinical Oncology, who assists drug development sponsors in study design and model selection for preclinical oncology studies, along with David Draper, Associate Director, Preclinical Oncology, who helps sponsors understand how in vitro services can be used effectively to address their preclinical investigational needs.